Neutralisation of IL12 p40 or IL23 p40 does not block infl ammation in multiple sclerosis

1 The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581–87. 2 The European Stroke Organisation (ESO) Executive Committee, the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovascular Dis 2008; 25: 457–507. 3 Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke: the eighth ACCP consensus conference on antithrombotic therapy. Chest 2008; 133: 630S–669S. 4 Meyer BC, Raman R, Hemmen T, et al. Effi cacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study. Lancet Neurol 2008; 7: 787–95. 5 Saver JL. Time is brain—quantifi ed. Stroke 2006; 37: 263–66.